XML 88 R30.htm IDEA: XBRL DOCUMENT v3.24.4
Organization and Business Description (Tables)
 12 Months Ended
Sep. 30, 2024
Organization and Business Description (Tables) [Line Items]  
Schedule of Consolidated Financial Statements of the Company The consolidated financial statements of the Company include the following entities:
Name of Entity   Date of
Incorporation		     Place of
Incorporation		   % of
Ownership		     Principal Activities
Jin Med     January 14, 2020      Cayman Island     Parent      Investment holding
                         
Zhongjin HK     February 25, 2020      Hong Kong     100%     Investment holding
                         
Erhua Med     September 24, 2020      PRC     100%     WFOE, Investment holding
                         
Changzhou Zhongjin     January 26, 2006      PRC     VIE      Design, development, manufacturing and sales of wheelchair and other mobility products
                         
Taizhou Zhongjin     June 17, 2013      PRC     100% controlled subsidiary of the VIE      Design, development, manufacturing and sales of wheelchair and other mobility products
                         
Zhongjin Jing’ao     December 18, 2014      PRC     100% controlled subsidiary of the VIE      Design, development, manufacturing and sales of wheelchair and other mobility products
                         
Zhongjin Kangma     August 21, 2023     PRC     80% controlled subsidiary of the VIE     Sales of wheelchair and other mobility products
                         
Anhui Zhongjin     October 7, 2023     PRC     100%     Newly incorporated – not in operation yet
VIE [Member]  
Organization and Business Description (Tables) [Line Items]  
Schedule of Financial Statement Amounts and Balances of the VIE and VIE’s Subsidiaries The following financial statement amounts and balances of the VIE and VIE’s subsidiaries were included in the accompanying consolidated financial statements after elimination of intercompany transactions and balances:
   September 30,
2024		   September 30,
2023		 
Current assets  $37,842,016   $24,391,558 
Non-current assets   1,971,681    1,787,635 
Total assets  $39,813,697   $26,179,193 
Current liabilities  $17,013,879   $8,763,714 
Non-current liabilities   96,175    
-
 
Total liabilities  $17,110,054   $8,763,714 
Schedule of Revenue
   For the Years Ended September 30, 
   2024   2023   2022 
Net revenue  $23,502,010   $19,821,457   $19,190,541 
Net income  $4,508,981   $3,438,466   $2,706,527 
Schedule of Cash Flow Statement
   For the Years Ended September 30, 
   2024   2023   2022 
Net cash provided by operating activities  $65,036   $3,566,639   $1,580,656 
Net cash used in investing activities   (9,370,058)   (2,430,248)   (120,904)
Net cash provided by (used in) financing activities  $11,204,749   $(213,892)  $121,855